epcoritamab
abbvie,genmab
['epcoritamab', 'lymphoma', 'congrat', 'dlbcl']
 is breaking the #lymphoma session today! presenting results of the phase 1/2 trial epcoritamab + r-dhax/c in r/r lbcl n=29
21/29 completed (pd 6/29, ae 2/29)
orr 100% in asct receptors 4/5 non-transplanted still on treatment congrats! #ash22 
Medical degree at @USAL | Internal Medicine student at @HematoCAUSA | Hematology and Hemotherapy at Hospital Ramón y Cajal @HematoRYC | PhD student at @UAHes